Smith & Nephew Acquiring Ceterix, Meniscal Repair Technology

Smith & Nephew (SNN) agreed to acquire Ceterix Orthopaedics, developer of the NovoStitch® Pro Meniscal Repair System, for up to US $105MM comprising an initial cash consideration of $50MM and $55MM over the next five years, contingent upon financial performance.

Ceterix received FDA 510(k) clearance to market the next-generation NovoStitch...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us